Overview

• Costco confirmed on August 14 that it will not seek FDA certification to dispense mifepristone at its more than 500 U.S. pharmacies.
• The company said low member demand drove its choice and declined to comment on whether outside advocacy influenced its decision.
• A coalition including Alliance Defending Freedom and Inspire Investing called the outcome a “very significant win” and announced plans to shift its campaign to other national chains.
• CVS Health and Walgreens Boots Alliance remain the only national retailers certified to dispense mifepristone in states where it is legally permitted.
• Telehealth and mail-order providers continue to supply the abortion pill nationwide despite new state bills aiming to restrict medication abortion and ongoing legal challenges to FDA’s REMS requirements.